Androgen Deprivation Therapy in Prostate Cancer: Looking Beyond Prostate-specific Antigen and Testosterone Levels

被引:4
|
作者
Saad, Fred [1 ]
机构
[1] Univ Montreal, Ctr Hosp, Montreal, PQ H2L 4M1, Canada
关键词
D O I
10.1016/j.eururo.2014.08.033
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:837 / 838
页数:2
相关论文
共 50 条
  • [31] Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
    B. Meller
    F. Bremmer
    C. O. Sahlmann
    S. Hijazi
    C. Bouter
    L. Trojan
    J. Meller
    P. Thelen
    [J]. EJNMMI Research, 5
  • [32] EFFECT OF EXOGENOUS TESTOSTERONE REPLACEMENT ON PROSTATE-SPECIFIC ANTIGEN AND PROSTATE-SPECIFIC MEMBRANE ANTIGEN LEVELS IN HYPOGONADAL MEN
    DOUGLAS, TH
    CONNELLY, RR
    MCLEOD, DG
    ERICKSON, SJ
    BARREN, R
    MURPHY, GP
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1995, 59 (04) : 246 - 250
  • [33] Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer-specific mortality
    Bitterman, Danielle S.
    Chen, Ming-Hui
    Wu, Jing
    Renshaw, Andrew A.
    Loffredo, Marian
    Kantoff, Philip W.
    Small, Eric J.
    D'Amico, Anthony V.
    [J]. CANCER, 2021, 127 (15) : 2623 - 2630
  • [34] CHANGES IN PROSTATE-SPECIFIC ANTIGEN AND PERCENT FREE PROSTATE-SPECIFIC ANTIGEN IN MEN TREATED WITH TESTOSTERONE REPLACEMENT THERAPY
    Morgentaler, A.
    Kaufman, J. M.
    Denes, B. S.
    Miller, M. G.
    Benesh, J. A.
    Kan-Dobrosky, N.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 207 - 208
  • [35] Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy
    Coward, Robert M.
    Simhan, Jay
    Carson, Culley C., III
    [J]. BJU INTERNATIONAL, 2009, 103 (09) : 1179 - 1183
  • [36] Prostate-specific antigen levels as a predictor of lethal prostate cancer
    Fall, Katja
    Garmo, Hans
    Andren, Ove
    Bill-Axelson, Anna
    Adolfsson, Jan
    Adami, Hans-Olov
    Johansson, Jan-Erik
    Holmberg, Lars
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07) : 526 - 532
  • [37] Prostate-specific Antigen Response and Eradication of Androgen Receptor Amplification with High-dose Testosterone in Prostate Cancer
    Schiff, Joshua P.
    Lewis, Brian E.
    Ledet, Elisa M.
    Sartor, Oliver
    [J]. EUROPEAN UROLOGY, 2017, 71 (06) : 997 - 998
  • [38] THE FALL AND RISE OF PROSTATE-SPECIFIC ANTIGEN - KINETICS OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER RADIATION-THERAPY FOR PROSTATE-CANCER
    ZAGARS, GK
    POLLACK, A
    [J]. CANCER, 1993, 72 (03) : 832 - 842
  • [39] Sensors for diagnosis of prostate cancer: Looking beyond the prostate specific antigen
    Dejous, Corinne
    Krishnan, Uma Maheswari
    [J]. BIOSENSORS & BIOELECTRONICS, 2021, 173
  • [40] Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels >20 ng/mL
    Berthelet, E
    Pickles, T
    Lee, KWJ
    Liu, M
    Truong, PT
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03): : 781 - 787